Wednesday, May 13, 2015

Advances in Personalized Medicine for Gyn Cancers - May 13,2015

Forty-five participants joined us for our May chat as we discussed Advances in Personalized Medicine. We were grateful to have Dr. Scott Richard (@sdr2md), Director of the Division of Gynecologic Oncology at Hahnemann University Hospital, and Kelly Mellott and Dr. Juan Avila from Helomics™ Corporation (@HelomicsCancer) share their expertise on this important and timely topic. Other participants included our health care moderators, researchers, health care providers, survivors and advocates. Chat analytics may be found here.

I've highlighted just a few of the tweets in response to our discussion questions.

T1A: What are some misconceptions you've heard about personalized medicine?

T1B: What personalized medicine options are currently available to gyn cancer patients? What is tested - tumor tissue, blood?



T2: How does genetic testing impact treatment decisions? What genetic tests are recommended for gyn cancers?

T3: How can I discuss personalized medicine options with my cancer care team? What if my doctor doesn't believe in these options?


T4A: How do you think the President’s Precision Medicine Initiative will affect patients/ research?

T4B: What are the challenges to bringing the benefit of personalized medicine to gyn cancer patients? How will patient care change?

If you want to read more of this informative discussion you may find the transcript here .

A list of resources shared by participants during the chat may be found at the end of this post.  

We hope you will join us on June 10, 2015 as we join with #hpm for a chat on Palliative Care. And be sure to watch for #gyncsm in tweets reporting the latest from the ASCO Annual meeting (#ASCO15, May 29-June 2).

Dee
#gyncsm co-founder and co-moderator

RESOURCES:

Precision Medicine and Targeted Therapy overview via @theNCI: http://t.co/OvBNHgBinH

Overview of immunotherapy tactics and trials for cervical and ovarian http://t.co/50EGJ4929S

@myriadgenetics: Companion Diagnostics Visit http://t.co/vjcgk78Kne

Personalized Cancer Therapy - MD Anderson https://pct.mdanderson.org/

Organizations active w/ GYN cancer Precision Medicine @HelomicsCancer @ClearityFnd @FoundationATCG @myriadgenetics @carisls @AmbryGene

Research explores new, personalized #ovariancancer treatments http://t.co/uGCZXNadXD

National Society of Genetics Counselors http://t.co/HJ6EgbJjxa

ASCO 2015 abstract PM and endometrial cancer- more to learn http://t.co/oJFl6EV8IG
ASCO abstract for PM and cervical cancer http://t.co/eSL3RnIXCv
ASCO abstract for ovarian cancer and PM http://t.co/PimP9Mx6aX

@CancerTodayMag article lists good questions to ask your Doctor http://t.co/zZrCctRxml

How to Talk so your Doctor Will Listen (not specific to PM) http://t.co/2VFICJBQDO

Patient resource for PM / olaparib treatment for #ovariancancer http://t.co/ovlGNH2J5F

Helomics™ Corporation :
patient section currently http://t.co/2vzrfni8gF
questions for your doctor for #ovariancancer: http://t.co/IllLM0Mav4
checklist to talk to your doctor for #endometrialcancer or #uterinecancer: http://t.co/gPQgDPYGmx

@myriadgenetics
“Personalizedmedicine is a game changer – it’s the future of medicine.”video   http://bit.ly/1OUi62f
#ovariancancer patient discussing PM http://t.co/8V7qPTjAtN

@permedcoalition The Case for Personalized Medicine - 4th Edition w/ Drugs/Relevant Gene Chart http://t.co/aYvmmjKmY3
Pg 6: % pts whose tumors driven by certain mutations could be targets for specific drugs, by cancer type http://t.co/Nm6Fg0wgLg

Bombarded w/Changes in Health Care & Beyond, Gyn Oncologists Prepare for the Challenges Ahead http://t.co/JcftUtVO0…

Fact Sheet President's Precision Medicine Initiative : https://t.co/A85dgI6S0E

#PARP inhibitors: A new era of targeted therapy #ovariancancer  http://t.co/73WAO2zmlM

Image of key pathways in #ovca  http://t.co/qR4qXxJBJS

Immune-Based Treatment Shows Promise against Metastatic Cervical Cancer http://t.co/4y4nFEGqkF

ovarian cancer FANG vaccine http://t.co/QXUAKclm6d

SGO genetic testing in gyn cancers: ovarian cancer https://t.co/lp5gWgW8FD
SGO Lynch testing statement for endometrial cancer https://t.co/lp5gWgW8FD
SGO statement on Next Gen multi- gene sequencing panels https://t.co/Mu8zBe3Y8r

Saving Tumor Tissue @OCRF Webinar http://t.co/FeYvQbk7Rq

@OncLive Search for Immune-specific biomarkers is in full swing: http://t.co/JXZRr00vPG

Imprecise marketing of precision medicine: Advertising may be running ahead of science http://t.co/cl1SKHbOvQ

Lecture by Dr. Funda Meric-Bernstam  MDACC https://t.co/n6w6exQQEf

Liquid Biopsies may change cancer care #gyncsm http://t.co/VD3MutGt78

@WSJhealth : A New Way to Use Old Tools Against #OvarianCancer http://t.co/L8dFeYl5h5

Friday, May 8, 2015

May Chat : Advances in Personalized Medicine for GYN Cancer

Our October 2013 chat topic was "Genetics and Personalized Medicine". Many new developments and initiatives have occurred since then. During our May 13, 2015 (9pm EST) chat we will provide an update on advances made in personalized medicine and how they impact the care of patients with gynecologic cancers.

In addition to our regular Health Care Moderators, Dr. Scott Richard (@sdr2md) Director of the Division of Gynecologic Oncology at Hahnemann University Hospital and Kelly Mellott and Dr. Juan Avila from Helomics™ Corporation (former known as Precision Therapeutics; they will be tweeting as @HelomicsCancer) will join us for this important discussion. Helomics™ Corporation is a healthcare company that develops innovative diagnostics for the oncology field. PLEASE NOTE: Helomics' participation in this chat is NOT an endorsement of the company's products or services by the #gyncsm community or our health care moderators.

The discussion questions are:

T1A: What are some misconceptions you've heard about personalized medicine?
T1B: What personalized medicine options are currently available to gyn cancer patients? What is tested - tumor tissue, blood?
T2: How does genetic testing impact treatment decisions? What genetic tests are recommended for gyn cancers?
T3: How can I discuss personalized medicine options with my cancer care team? What if my doctor doesn't believe in these options?
T4A: How do you think the President’s Precision Medicine Initiative will affect patients/ research?
T4B: What are the challenges to bringing the benefit of personalized medicine to gyn cancer patients? How will patient care change?

To prepare for our discussion you may read  President Obama's Precision Medicine Initiative Fact Sheet . Additional articles/resources may be found on the CDC's Public Health Genomics page and on the NCI's Precision Medicine and Targeted Therapy page.

We look forward to having you join our discussion or come and "lurk and learn".

Dee
#gyncsm co-founder and co-moderator